Adding docetaxel to androgen deprivation therapy (ADT) plus radiation therapy (RT) failed to improve survival in unfavorable-risk prostate cancer, though the combination may hold benefit for certain ...

A total of 82 patients with HRPC were included. Of these, 71 patients were selected for second-line chemotherapy based on two or more consecutive increases in PSA not <14 days apart and/or objective ...

The FDA issued an alert last Friday that some patients have reported feeling intoxicated after receiving their infusions of the chemotherapeutic drug, docetaxel. The agency will be requiring companies ...

There are a number of generic docetaxel products now available in the United States, since the patent on the branded version of docetaxel (Taxotere, Sanofi) expired in 2011. But now, for the first ...

Darolutamide plus androgen deprivation therapy (ADT), without docetaxel, significantly prolonged radiographic progression-free survival compared with placebo plus ADT in patients with metastatic ...

Survival curves for men treated with and without add-on docetaxel converged with longer follow-up. Based on 10 years of trial follow-up data, docetaxel should not be used to treat high-risk localized ...

Are you taking Docetaxel? Are you aware of the dangers of combining Docetaxel with certain foods and herbs? Drug-food-interactions are seldom discussed but can lead to undesirable side effects and ...

Among microtubule-targeting agents, docetaxel has received recent interest owing to its good therapeutic index. Clinical trials have underlined its potential for the treatment of advanced breast ...

Consistent OS benefit in an Asian subset with a strong HR of 0.69 for non-squamous patients, and meaningful safety advantage position Plinabulin as a late-stage candidate showing survival improvement ...